학술논문

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors
Document Type
Journal
Source
CANCERS; FEB 2022, 14 3, p702 12p.
Subject
Language
English
ISSN
20726694